Moleculin Biotech (MBRX) Exchange Rate Effect (2018 - 2025)
Moleculin Biotech (MBRX) posted quarterly Exchange Rate Effect of $54000.0 for Q4 2025, up 220.0% year-over-year from $16875.0 in Q4 2024, and up 1000.0% quarter-over-quarter from -$6000.0 in Q3 2025.
Moleculin Biotech (MBRX) Exchange Rate Effect (2018 - 2025) Analysis & Trends
Moleculin Biotech's Exchange Rate Effect history runs 8 years deep, the most recent figure standing at $54000.0 for Q4 2025.
- In Q4 2025, Exchange Rate Effect rose 220.0% year-over-year to $54000.0; the TTM figure through Dec 2025 stood at $51000.0 (up 259.38% YoY), while the FY2025 annual figure was $51000.0, up 259.38% from the prior year.
- Exchange Rate Effect for Q4 2025 stood at $54000.0, up from -$6000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $54000.0 in Q4 2025, with the low at -$45000.0 in Q4 2024.
- The 5-year median for Exchange Rate Effect is -$4000.0 (2021), against an average of -$2894.7.
- Peak annual rise in Exchange Rate Effect reached 900.0% in 2024, while the deepest fall reached 650.0% in 2024.
- Moleculin Biotech's Exchange Rate Effect stood at $2000.0 in 2021, then surged by 350.0% to $9000.0 in 2022, then plunged by 166.67% to -$6000.0 in 2023, then slumped by 650.0% to -$45000.0 in 2024, then jumped by 220.0% to $54000.0 in 2025.
- Business Quant data shows MBRX's Exchange Rate Effect at $54000.0 in Q4 2025, -$6000.0 in Q3 2025, and $3000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.39 Bn | 132.54 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 86.47 Bn | 78.47 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 65.25 Bn | 60.07 Bn | 1.37 Bn | - |
| 4 | Moderna | 61.79 Bn | 56.66 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 42.27 Bn | 37.17 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 31.17 Bn | 27.86 Bn | 992.69 Mn | -2.45 Mn |
| 7 | BioNTech SE | 28.61 Bn | 10.22 Bn | 668.28 Mn | 1.63 Mn |
| 8 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | -287,000.00 |
| 9 | Royalty Pharma | 27.30 Bn | 26.46 Bn | - | - |
| 10 | Moleculin Biotech | 3.47 Mn | 3.47 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 54,000.00 |
| Dec 31, 2025 | 54,000.00 |
| Sep 30, 2025 | -6,000.00 |
| Sep 30, 2025 | -6,000.00 |
| Mar 31, 2025 | 3,000.00 |
| Mar 31, 2025 | 3,000.00 |
| Dec 31, 2024 | -45,000.00 |
| Dec 31, 2024 | -45,000.00 |
| Sep 30, 2024 | 14,000.00 |
| Sep 30, 2024 | 14,000.00 |
| Jun 30, 2024 | 8,000.00 |
| Jun 30, 2024 | 8,000.00 |
| Mar 31, 2024 | -9,000.00 |
| Mar 31, 2024 | -9,000.00 |
| Dec 31, 2023 | -6,000.00 |
| Dec 31, 2023 | -6,000.00 |
| Sep 30, 2023 | -10,000.00 |
| Sep 30, 2023 | -10,000.00 |
| Jun 30, 2023 | -1,000.00 |
| Jun 30, 2023 | -1,000.00 |